N/A N=12 Device Feasibility

Feasibility of a Mobile Application to Support Reflection and Dialog About Strengths in People With Chronic Illness

Chronic Disease · Rheumatic Diseases

Bottom Line

View on ClinicalTrials.gov: NCT03437863 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2021

Primary outcome: Primary: Perceived Usefulness of the Application — 12; 0; 0; 0 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Mobile application (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Oslo University Hospital
Primary completion: Sep 2018

Outcome Measures

Outcome	Result	p-value
PRIMARY Perceived Usefulness of the Application	12; 0; 0; 0; 9; 1	—
PRIMARY The System Usability Scale	86.3	—
SECONDARY The Positive and Negative Affect Schedule.	34.0; 35.0; 12.0; 11.0	—
SECONDARY The Arthritis Self-efficacy Scale	12.0; 14.0; 16.0; 17.0	—

Summary

Self-management of chronic illness can be highly demanding and people need to mobilize their personal strengths in order to live well with their condition. A mobile application was designed in collaboration with people with chronic illness and health care providers with the aims to support awareness of patients' strengths and patient-provider dialogues that include strengths. The aim of the present study is to evaluate with mixed methods the perceived usefulness and usability of the application and potential effects of the application on patients.

Eligibility Criteria

Setting 1:

Inclusion Criteria

Age of 18 years or older
Can read and speak Norwegian language
Diagnosed with a chronic condition
Participating or having recently participated in a learning and mastery or an outpatient rehabilitation program

No exclusion criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03437863). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.